This combinatorial nanotrain can reverse the drug resistance of BC stem cells (BCSCs), including apoptosis resistance and ABC transporters overexpression, via the AKT signaling pathway in MCF7 cells and xenografting BCSCs into nude mice [58]. This evidence concerns the gene AKT1 and breast cancer.